Ann: Shareholder Update , page-14

At the end of May 2012, we announced the achievement
of a significant research milestone in our Collaboration and
License agreement with Pfizer to discover novel peptide-based
vaccines. This milestone followed the successful completion
of the first stage of the collaboration, which was announced
in December 2010. Under the terms of the agreement, the
recent milestone achievement triggered an undisclosed
financial payment, which was received in July 2012.
We are particularly excited to have reached this research
milestone in our collaboration with Pfizer because it represents the first step towards our partner potentially exercising its option to a commercial licence within the coming months.
Doug Wilson PYC Newsletter July2012

SoT,
I believe they used the terms "successful" "findings" for both the MedImmune and Pfizer collaboration results also, but now no mention, so sorry if I don't get to excited about PYC reporting "successful findings" with Roche. I'm pragmatic, so I expect "successful findings" to at least translate into some sort of revenue.

11 years in and they are finally finding what Phylomers could be used for...nice...but still have to develop the technology/platform. If this was year 1 or 2, I would say great...year 12...not so much.

I also would like to hear responses to Heks questions. Tony & Wayne are always posting about their "excitement" and "breakthroughs" and a license or buyout is right around the corner ((its been around the corner for quite some time by their comments)), so how do they explain the disconnect between the reality of PYC's progress (both financial and in terms of deals) and all the continued hype around the potential of the platform that you say is there??


AND no I don't care if you keep negative rating my posts. Me likes the 0 ratings.